Abstract:ObjectiveTo explore the clinical application value of half-ICSI treatment for infertility in assisted reproductive technology. MethodA retrospective analysis of 1130 half-ICSI treatments was conducted at the Affiliated Reproductive Hospital of Shandong University from January 2011 to December 2015. Patients with low fertilization rates in previous cycles, primary infertility for >5 years with unexplained reason, or secondary infertility for >5 years without fallopian tube factor were involved in this study. The 2PN rate, high-quality embryo rate, oocyte utilization rate, and clinical outcomes were compared between IVF insemination group (IVF group) and ICSI insemination group (ICSI group). The clinical outcome of half-ICSI insemination treatment, grouped according primary and secondary infertility, was also analyzed. ResultsCompared with IVF, ICSI resulted in a significantly higher 2PN rate (74.8% vs. 62.9%), high-quality embryo rate (54.6% vs. 51.7%), and oocyte utilization rate (35.9% vs. 32.8%; P<0.05). Among the 884 fresh-embryo transfer cycles, there were no notable differences in clinical pregnancy rate, live birth rate, or neonatal abnormality rate between the IVF and ICSI groups. Among the 792 primary infertility cycles, ICSI resulted in a significantly higher 2PN rate, high-quality embryo rate, and oocyte utilization rate compared with IVF (75.3% vs. 62.4%, 54.3% vs. 50.8%, 36.4% vs. 32.6%, P<0.05). For the 338 secondary infertility cycles, ICSI resulted in a significantly higher 2PN rate (73.6% vs. 63.9%, P<0.05) compared with IVF, but there were no notable differences in other laboratory results. Moreover, the biochemical pregnancy rate of the ICSI group was significantly lower than for IVF in secondary infertility cycles (49.3% vs. 65.6%; P<0.05). A total of 89 cycles (7.9%) with complete IVF fertilization failure showed a low second polar body (2PB) rate (33.6%) after a 5-h short-time fertilization period, including 34 cycles (3.0%) with no 2PB oocytes observed in the IVF group. ConclusionICSI insemination improved laboratory results compared with IVF insemination, however, fresh-embryo transfer of ICSI originated embryos did not improve clinical pregnancy and live birth rates. Rescue ICSI has been successfully applied in clinical IVF insemination to avoid fertilization failure. Therefore, as an extra intervention, it is suggested that ICSI be used judiciously.

Clinical Application Indications and Safety Analysis of ICSI

Research on the clinical application of intracytoplasmic sperm injection

Intracytoplasmic Sperm Injection Versus Conventional In-Vitro Fertilisation for Couples with Infertility with Non-Severe Male Factor: a Multicentre, Open-Label, Randomised Controlled Trial

Clinical Variables Affecting the Pregnancy Rate of Intracervical Insemination Using Cryopreserved Donor Spermatozoa: A Retrospective Study in China

[The Evaluation of 156 Cycles of Intracytoplasmic Sperm Injection in the Management of Male Infertility and Idiopathic Infertility].

Advances in Safety Assessment of Intracytoplasmic Sperm Injection

Research progress on the effectiveness and offspring safety of intracytoplasmic sperm injection technology

Is Intracytoplasmic Sperm Injection the Solution for All in Unexplained Infertility?

Clinical Analysis of Intracytoplasmic Sperm Injection in Patients with Previous Fertilization Failure after Conventional IVF

Evolution of intracytoplasmic sperm injection: From initial challenges to wider applications

The impact of intracytoplasmic sperm injection versus conventional in vitro fertilization on the reproductive outcomes of couples with non-male factor infertility and frozen-thawed embryo transfer cycles

The effect of ICSI in infertility couples with non-male factor: a systematic review and meta-analysis

Research progress in outcome and safety of ICSI by different origin of sperm]

Intracytoplasmic Sperm Injection May Not Improve Clinical Outcomes Despite Its Positive Effect on Embryo Results: A Retrospective Analysis of 1130 Half-ICSI Treatments

Efficacy of Intracytoplasmic Sperm Injection in Women with Non-Male Factor Infertility: A Systematic Review and Meta-Analysis.

[Intracytoplasmic Sperm Injection in the Management of Male Infertility and Idiopathic Fertilization Failure].

Intracytoplasmic Sperm Injection Improves Normal Fertilization Rate and Clinical Pregnancy Rate in Male Infertility

[Intracytoplasmic Injection with Sperm from Ejaculation, Epididymis and Testis in Treating Different Male Infertility with Oligo-Asthenozoospermia or Azoospermia ].

[Indications and Clinical Outcomes of Half-Icsi in 99 Cases].

A brief history of technical developments in intracytoplasmic sperm injection (ICSI). Dedicated to the memory of J.M. Cummins

Safety evaluation of single-sperm cryopreservation technique applied in intracytoplasmic sperm injection